Effects of Tralokinumab in the Skin: an Immunologic and Molecular Investigation

Clinical trial NCT05378698 · TERMINATED

Trial details

NCT number: NCT05378698
Sponsor: University of Zurich
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2022-06-15
Primary completion: 2025-03-04
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.